Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01292915

Acronym

NIS-PUB

Enrollment

1044

Registered

2011-02-10

Start date

2011-10-31

Completion date

2013-01-31

Last updated

2014-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Re-bleeding in NVUGIB

Keywords

Re-bleeding, NVUGIB

Brief summary

The main aim of the study is to describes the outcomes of patients with Upper Gastrointestinal Bleed (UGIB) in a real-life setting. Additionally analyse assessed predictors of outcome, including the impact of hemostatic endoscopic and pharmacologic therapies.

Detailed description

MSD

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients (\>=18yrs) admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia... * Evidence that an upper GI endoscopy was performed

Exclusion criteria

* GI bleeding not from NVUGIB

Design outcomes

Primary

Measure	Time frame
Rebleeding (within 7 days from the Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB) episode)	7 days

Secondary

Measure	Time frame
Surgery due to re-bleeding	7 days
Mortality due to bleeding	7 days
Rebleeding in high risk peptic ulcer patients	7 days

Countries

Vietnam

Outcome results